RYBELSUS is an oral medication prescribed for the treatment of type 2 diabetes. It contains the active ingredient semaglutide, which belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. RYBELSUS works by stimulating insulin release in response to high blood sugar levels, thereby helping to lower blood sugar levels. It also slows down the digestion process, which can help reduce appetite and potentially lead to weight loss. Unlike other forms of semaglutide that are administered through injections, RYBELSUS is taken orally, making it a convenient option for those seeking an alternative to injectable diabetes medications. It is typically prescribed alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes.